skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines lutetium (177Lu) oxodotreotideQuestion & answer

lutetium (177Lu) oxodotreotide · Medicine question

Why are amino acids given with treatment?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

Lysine and arginine reduce reabsorption of the radiopharmaceutical in the kidneys, lowering kidney radiation exposure.

Sources for this answer

Lutathera 370 MBq/mL solution for infusionemc · SmPC Current selected SmPC · Version 8

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

lutetium (177Lu) oxodotreotide

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the lutetium (177Lu) oxodotreotide guide

More questions about lutetium (177Lu) oxodotreotide

What is lutetium (177Lu) oxodotreotide used to treat?Is lutetium (177Lu) oxodotreotide chemotherapy?Why is a receptor scan needed before treatment?How is it given?Why are radiation precautions needed?Can it cause sickness?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX